AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 1-25/54
STUDY OF THE FREQUENCIES OF CYP1A1 GENE POLYMORPHISMS AND GLUTATHIONE-S-TRANSFERASE MU1 GENE IN PRIMARY BREAST CANCERS - AN UPDATE WITH AN ADDITIONAL 114 CASES
Authors: FONTANA X PEYROTTES I ROSSI C LEBLANCTALENT P ETTORE F NAMER M BUSSIERE F
Citation: X. Fontana et al., STUDY OF THE FREQUENCIES OF CYP1A1 GENE POLYMORPHISMS AND GLUTATHIONE-S-TRANSFERASE MU1 GENE IN PRIMARY BREAST CANCERS - AN UPDATE WITH AN ADDITIONAL 114 CASES, Mutation research. Fundamental and molecular mechanisms of mutagenesis, 403(1-2), 1998, pp. 45-53
CISPLATIN CARBOPLATIN/CYCLOPHOSPHAMIDE (CCP) VS CISPLATIN/CYCLOPHOSPHAMIDE (CP) IN STAGE III-IV EPITHELIAL OVARIAN-CANCER - A FRENCH RANDOMIZED PHASE-III STUDY/
Authors: HERON JF JOLY F KERBRAT P CHAUVERGNE J MAYER F WEBER B CHINETCHARROT P CROUET H GOUPIL A LESECH JM LEBRUNJEZEKOVA D NAMER M MARTIN C GUASTALLA JP LHOMME C
Citation: Jf. Heron et al., CISPLATIN CARBOPLATIN/CYCLOPHOSPHAMIDE (CCP) VS CISPLATIN/CYCLOPHOSPHAMIDE (CP) IN STAGE III-IV EPITHELIAL OVARIAN-CANCER - A FRENCH RANDOMIZED PHASE-III STUDY/, Annals of oncology, 9, 1998, pp. 315-315
ALTERNATING AND SEQUENTIAL SCHEDULES OF TAXOTERE FEC-75 IN THE FIRST LINE TREATMENT OF METASTATIC BREAST-CANCER/
Authors: TUBIANAHULIN M NAMER M TUBIANAMATHIEU N PIOT G EYMARD JC BOUGNOUX P CULINE S MANSOURI H BOCCARA C SPIELMANN M
Citation: M. Tubianahulin et al., ALTERNATING AND SEQUENTIAL SCHEDULES OF TAXOTERE FEC-75 IN THE FIRST LINE TREATMENT OF METASTATIC BREAST-CANCER/, Annals of oncology, 9, 1998, pp. 570-570
PHASE-III STUDY - TAXOTERE(R) (TXT) VERSUS 5-FLUOROURACIL PLUS NAVELBINE (FUN) IN PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC) AS 2NDLINE CHEMOTHERAPY (CT) (PRELIMINARY-RESULTS)
Authors: MONNIER A BONNETERRE J ROCHE H FARGEOT P NAMER M GUASTALLA JP RIOS M SERIN D CULINE S TUBIANA M EYMARD JC ASSADOURIAN S
Citation: A. Monnier et al., PHASE-III STUDY - TAXOTERE(R) (TXT) VERSUS 5-FLUOROURACIL PLUS NAVELBINE (FUN) IN PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC) AS 2NDLINE CHEMOTHERAPY (CT) (PRELIMINARY-RESULTS), Annals of oncology, 9, 1998, pp. 580-580
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
POSITION OF THE ON-NATIONALE-DES-CENTRES-DE-LUTTE-CONTRE-LE-CANCER (JULY 3, 1998)
Authors: EISINGER F ESPIE M KUTTENN F LASSET C DELIGNIERES B NAMER M ROCHE H SASCO A SERIN D PHILIP T
Citation: F. Eisinger et al., POSITION OF THE ON-NATIONALE-DES-CENTRES-DE-LUTTE-CONTRE-LE-CANCER (JULY 3, 1998), Bulletin du cancer, 85(8), 1998, pp. 725-725
ADJUVANT TREATMENTS OF SURGICAL BREAST-CANCER
Authors: KERBRAT P NAMER M
Citation: P. Kerbrat et M. Namer, ADJUVANT TREATMENTS OF SURGICAL BREAST-CANCER, Bulletin du cancer, 85(6), 1998, pp. 589-590
PRELIMINARY-RESULTS OF NSABP TRIAL FOR PR EVENTION OF BREAST-CANCER
Authors: NAMER M
Citation: M. Namer, PRELIMINARY-RESULTS OF NSABP TRIAL FOR PR EVENTION OF BREAST-CANCER, Bulletin du cancer, 85(4), 1998, pp. 299-299
PROSPECTIVE RANDOMIZED STUDY OF MITOXANTRONE(M) AND VINORELBINE(V) VSFAC OR FEC IN ABC
Authors: NAMER M TURPIN F SERIN D GANEM G CALAIS G MAILLART P COLIN P PREVOST G ROMESTAING P TIGAUT JD CLAVERE P
Citation: M. Namer et al., PROSPECTIVE RANDOMIZED STUDY OF MITOXANTRONE(M) AND VINORELBINE(V) VSFAC OR FEC IN ABC, British Journal of Cancer, 78, 1998, pp. 74-74
RANDOMIZED PHASE-II STUDY OF CISPLATIN AND 5-FLUOROURACIL (5-FU) VERSUS CISPLATIN ALONE IN ADVANCED SQUAMOUS-CELL ESOPHAGEAL CANCER
Authors: BLEIBERG H CONROY T PAILLOT B LACAVE AJ BLIJHAM G JACOB JH BEDENNE L NAMER M DEBESI P GAY F COLLETTE L SAHMOUD T
Citation: H. Bleiberg et al., RANDOMIZED PHASE-II STUDY OF CISPLATIN AND 5-FLUOROURACIL (5-FU) VERSUS CISPLATIN ALONE IN ADVANCED SQUAMOUS-CELL ESOPHAGEAL CANCER, European journal of cancer, 33(8), 1997, pp. 1216-1220
ADJUVANT CHEMOTHERAPY WITH AC VERSUS HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE (MC), FILGRASTRIM IN OPERABLE BREAST-CANCER INVOLVING 10 OR MORE AXILLARY LYMPH-NODES - 3 YEARS FOLLOW-UP RESULTS
Authors: FUMOLEAU P CHAUVIN F NAMER M BUGAT R TUBIANAHULIN M GUASTALLA JP DELOZIER T KERBRAT P DEVAUX Y FILLEUL A
Citation: P. Fumoleau et al., ADJUVANT CHEMOTHERAPY WITH AC VERSUS HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE (MC), FILGRASTRIM IN OPERABLE BREAST-CANCER INVOLVING 10 OR MORE AXILLARY LYMPH-NODES - 3 YEARS FOLLOW-UP RESULTS, European journal of cancer, 33, 1997, pp. 351-351
PROSPECTIVE RANDOMIZED STUDY OF MITOXANTRONE (M) AND VINORELBINE (V) VS FLUOROURACIL(F), EPIRUBICIN (E) OR ADRIAMYCIN (A) AND CYCLOPHOSPHAMIDE (C) IN PATIENTS WITH ADVANCED BREAST-CANCER (ABC)
Authors: TURPIN F SERIN D GANEM G CALAIS G MAILLART P COLIN P PREVOST G ROMESTAING P TIGAUT JD CLAVERE P NAMER M
Citation: F. Turpin et al., PROSPECTIVE RANDOMIZED STUDY OF MITOXANTRONE (M) AND VINORELBINE (V) VS FLUOROURACIL(F), EPIRUBICIN (E) OR ADRIAMYCIN (A) AND CYCLOPHOSPHAMIDE (C) IN PATIENTS WITH ADVANCED BREAST-CANCER (ABC), European journal of cancer, 33, 1997, pp. 647-647
ACTIVITY OF GEMCITABINE IN METASTATIC BREAST-CANCER (MBC) PATIENTS PREVIOUSLY TREATED WITH ANTHRACYCLINE-CONTAINING REGIMENS
Authors: SPIELMANN M KALLA S LLOMBARTCUSSAC A ESPIE M NAMER M FERRERO JM CUVIER C FUMOLEAU P PONZIO A KAYITALIRE L POUILLART P
Citation: M. Spielmann et al., ACTIVITY OF GEMCITABINE IN METASTATIC BREAST-CANCER (MBC) PATIENTS PREVIOUSLY TREATED WITH ANTHRACYCLINE-CONTAINING REGIMENS, European journal of cancer, 33, 1997, pp. 663-663
PHASE-II STUDY OF IRINOTECAN IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER IN CHEMOTHERAPY-NAIVE PATIENTS AND PATIENTS PRETREATED WITH FLUOROURACIL-BASED CHEMOTHERAPY
Authors: ROUGIER P BUGAT R DOUILLARD JY CULINE S SUC E BRUNET P BECOUARN Y YCHOU M MARTY M EXTRA JM BONNETERRE J ADENIS A SEITZ JF GANEM G NAMER M CONROY T NEGRIER S MERROUCHE Y BURKI F MOUSSEAU M HERAIT P MAHJOUBI M
Citation: P. Rougier et al., PHASE-II STUDY OF IRINOTECAN IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER IN CHEMOTHERAPY-NAIVE PATIENTS AND PATIENTS PRETREATED WITH FLUOROURACIL-BASED CHEMOTHERAPY, Journal of clinical oncology, 15(1), 1997, pp. 251-260
NONSPECIFICALLY LABELED CELLS THAT SIMULATE BONE-MARROW METASTASES INPATIENTS WITH NONMETASTATIC BREAST-CANCER
Authors: LAGRANGE M FERRERO JM LAGRANGE JL MACHIAVELLO JC MONTICELLI J BAYLE C CREISSON A NAMER M THYSS A BOURCIER C GIOANNI J SCHNEIDER M
Citation: M. Lagrange et al., NONSPECIFICALLY LABELED CELLS THAT SIMULATE BONE-MARROW METASTASES INPATIENTS WITH NONMETASTATIC BREAST-CANCER, Journal of Clinical Pathology, 50(3), 1997, pp. 206-211
PROGNOSTIC VALUE OF EARLY NORMALIZATION O F CA-125 DURING THE INDUCTION CHEMOTHERAPY IN STAGE-III AND STAGE-IV OVARIAN-CARCINOMA
Authors: FERRERO JM LARGILLIER R RAMAIOLI A HEUDIER P TEISSIER E NAMER M
Citation: Jm. Ferrero et al., PROGNOSTIC VALUE OF EARLY NORMALIZATION O F CA-125 DURING THE INDUCTION CHEMOTHERAPY IN STAGE-III AND STAGE-IV OVARIAN-CARCINOMA, Bulletin du cancer, 84(7), 1997, pp. 722-728
NEOADJUVANT CHEMOTHERAPY OF LOCALLY ADVAN CED BREAST-CANCER - HISTORICAL COMPARISON OF 4 SEQUENTIAL COMBINATIONS
Authors: FERRERO JM NAMER M DUFOUR JF LARGILLIER R CREISSON A TEISSIER E MACHIAVELLO JC LALLEMENT M MONTICELLI J ABBES M
Citation: Jm. Ferrero et al., NEOADJUVANT CHEMOTHERAPY OF LOCALLY ADVAN CED BREAST-CANCER - HISTORICAL COMPARISON OF 4 SEQUENTIAL COMBINATIONS, Bulletin du cancer, 84(1), 1997, pp. 10-16
LATE DELAYED ADJUVANT TAMOXIFEN IN EARLY BREAST-CANCER - RESULTS OF ACOOPERATIVE RANDOMIZED TRIAL
Authors: DELOZIER T SWITSERS O GENOT JY OLLIVIER JM HERY M NAMER M FRENAY M KERBRAT P JULIEN JP NAJA A JANVIER M MACELESECH J
Citation: T. Delozier et al., LATE DELAYED ADJUVANT TAMOXIFEN IN EARLY BREAST-CANCER - RESULTS OF ACOOPERATIVE RANDOMIZED TRIAL, Bulletin du cancer, 84(1), 1997, pp. 25-30
GLUTATHIONE-S-TRANSFERASE MU-1 (GSTM1) - BREAST-CANCER SUSCEPTIBILITYGENE
Authors: FONTANA X PEYROTTE I VALENTE E ROSSI C ETTORE F NAMER M BUSSIERE F
Citation: X. Fontana et al., GLUTATHIONE-S-TRANSFERASE MU-1 (GSTM1) - BREAST-CANCER SUSCEPTIBILITYGENE, Bulletin du cancer, 84(1), 1997, pp. 35-40
TREATMENT RESPONSE IN METASTATIC BREAST-CANCER - A MULTICENTER STUDY COMPARING UICC CRITERIA AND TUMOR-MARKER CHANGES
Authors: VANDALEN A HEERING KJ BARAK V PERETZ T CREMASCHI A GERONI P GION M SARACCHINI S MOLINA R NAMER M STIEBER P STURGEON C LEONARD RCF EINARSSON R
Citation: A. Vandalen et al., TREATMENT RESPONSE IN METASTATIC BREAST-CANCER - A MULTICENTER STUDY COMPARING UICC CRITERIA AND TUMOR-MARKER CHANGES, Breast, 5(2), 1996, pp. 82-88
RESULTS OF MASS-SCREENING PROGRAMS FOR BR EAST-CANCER IN FRANCE
Authors: MAMELLE N LACOUR A ARNOLD F BAZIN B BOHEC C BREGEAULT A CHAPERON J DUBUC M DURU G EXBRAYAT C FONTAINE D OBADIA Y PIETTE C SANMARCO JL SCHAFFER P TRUGEON A MANUEL C BREMOND A CHARLES R COHEN M DUBREUIL A NAMER M CORDIER B RENAUD R THIRION M WINCKEL P BOLLA M GIORDANELLA JP BENECH JM ALLEMAND H
Citation: N. Mamelle et al., RESULTS OF MASS-SCREENING PROGRAMS FOR BR EAST-CANCER IN FRANCE, La Presse medicale, 25(35), 1996, pp. 1663-1666
HORMONE-THERAPY FOR METASTASIC BREAST-CAN CER IN MENOPAUSED WOMEN
Authors: NAMER M
Citation: M. Namer, HORMONE-THERAPY FOR METASTASIC BREAST-CAN CER IN MENOPAUSED WOMEN, La Presse medicale, 25(35), 1996, pp. 1745
EVALUATION OF INDIVIDUAL BREAST-CANCER SC REENING IN THE ALPES-MARITIMES, FRANCE
Authors: FONTAS P BREGEAULT A MAESTRO C NAMER M OBADIA Y ROTILY M
Citation: P. Fontas et al., EVALUATION OF INDIVIDUAL BREAST-CANCER SC REENING IN THE ALPES-MARITIMES, FRANCE, Journal de radiologie, 77(9), 1996, pp. 657-662
FOLLOW-UP OF 153 MELANOMA EVALUABLE PATIENTS TREATED BY FOTEMUSTINE -PROGNOSIS FACTORS FOR RESPONSE AND SURVIVAL
Authors: KHAYAT D BANZET P WEIL M FUMOLEAU P AVRIL MF NAMER M BONNETERRE J KERBRAT P BONERANDI JJ BUGAT R MONTCUQUET P CUPISSOL D LAUVIN R VILMER C BOAZIZ C COUR V BIZZARI JP
Citation: D. Khayat et al., FOLLOW-UP OF 153 MELANOMA EVALUABLE PATIENTS TREATED BY FOTEMUSTINE -PROGNOSIS FACTORS FOR RESPONSE AND SURVIVAL, Medicamentos de actualidad, 32, 1996, pp. 35-41
AGE-RELATED DIFFERENCE IN TAMOXIFEN DISPOSITION
Authors: PEYRADE F FRENAY M ETIENNE MC RUCH F GUILLEMARE C FRANCOIS E NAMER M FERRERO JM MILANO G
Citation: F. Peyrade et al., AGE-RELATED DIFFERENCE IN TAMOXIFEN DISPOSITION, Clinical pharmacology and therapeutics, 59(4), 1996, pp. 401-410
Risultati: 1-25 | 26-50 | 51-54